Media stories about National Health Investors (NYSE:NHI) have trended somewhat positive recently, Accern reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. National Health Investors earned a news impact score of 0.13 on Accern’s scale. Accern also gave media stories about the real estate investment trust an impact score of 46.0842787819339 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

National Health Investors stock opened at $67.06 on Thursday. The stock has a market capitalization of $2,859.07, a P/E ratio of 17.33, a P/E/G ratio of 3.55 and a beta of 0.48. National Health Investors has a 12-month low of $62.71 and a 12-month high of $81.60. The company has a debt-to-equity ratio of 0.87, a current ratio of 13.85 and a quick ratio of 13.85.

How to Become a New Pot Stock Millionaire

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Friday, February 16th. The real estate investment trust reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.33 by ($0.43). The business had revenue of $71.06 million during the quarter, compared to the consensus estimate of $71.36 million. National Health Investors had a net margin of 57.19% and a return on equity of 12.20%. equities analysts anticipate that National Health Investors will post 5.49 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 10th. Investors of record on Friday, March 30th will be given a $1.00 dividend. The ex-dividend date is Wednesday, March 28th. This is a boost from National Health Investors’s previous quarterly dividend of $0.95. This represents a $4.00 annualized dividend and a yield of 5.96%. National Health Investors’s dividend payout ratio is 98.19%.

A number of analysts have recently commented on the company. KeyCorp reissued an “underweight” rating on shares of National Health Investors in a research report on Tuesday, December 19th. Stephens set a $79.00 price target on National Health Investors and gave the stock a “buy” rating in a research report on Friday, January 12th. Cantor Fitzgerald reissued a “hold” rating and issued a $85.00 price target on shares of National Health Investors in a research report on Wednesday, January 17th. SunTrust Banks set a $75.00 price target on National Health Investors and gave the stock a “hold” rating in a research report on Monday, January 22nd. Finally, ValuEngine cut National Health Investors from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. National Health Investors presently has an average rating of “Hold” and an average price target of $77.75.

In other National Health Investors news, VP John L. Spaid acquired 500 shares of the stock in a transaction that occurred on Thursday, February 22nd. The shares were acquired at an average cost of $64.95 per share, with a total value of $32,475.00. Following the transaction, the vice president now owns 971 shares of the company’s stock, valued at approximately $63,066.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO D. Eric Mendelsohn acquired 2,000 shares of the stock in a transaction that occurred on Thursday, February 22nd. The stock was acquired at an average cost of $65.47 per share, for a total transaction of $130,940.00. Following the completion of the transaction, the chief executive officer now directly owns 10,580 shares in the company, valued at approximately $692,672.60. The disclosure for this purchase can be found here. Insiders purchased a total of 2,812 shares of company stock worth $183,910 over the last ninety days. 5.19% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.watchlistnews.com/national-health-investors-nhi-receives-daily-coverage-optimism-score-of-0-13/1954761.html.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.